Alterations in microRNA expression profiles in inflamed and noninflamed ascending colon mucosae of patients with active Crohn's disease.

Researchers studied tiny genetic molecules called microRNAs in the colon tissue of patients with active Crohn's disease, a chronic inflammatory bowel condition. They collected tissue samples from both inflamed and non-inflamed areas of the ascending colon (the right side of the large intestine) in adults with active Crohn's disease and compared them to healthy tissue.

The study found dramatic differences in microRNA patterns. In inflamed tissue, 43 microRNAs were increased and 35 were decreased compared to healthy controls. Interestingly, even tissue that appeared non-inflamed showed 20 microRNAs with altered expression, and nearly 100 microRNAs differed between inflamed and non-inflamed areas. The researchers also identified thousands of altered messenger RNAs (the genetic instructions for making proteins) and discovered that one specific microRNA called hsa-miR-16-1 directly controls a gene called C10orf54, which may play a role in disease development.

For patients with Crohn's disease considering complementary therapies, these findings help explain the complex biological changes happening in the intestinal lining. Understanding which genes are turned on or off during inflammation could eventually help identify who might benefit most from various treatments, including integrative approaches like acupuncture. While this research doesn't directly study acupuncture, it provides insight into the inflammatory processes that acupuncture may help modulate. Some patients report that acupuncture helps manage Crohn's symptoms including abdominal pain, stress, and overall well-being. If you're considering acupuncture for Crohn's disease management, consult with a licensed acupuncturist experienced in treating digestive disorders.

This study characterized microRNA and mRNA expression profiles in ascending colon mucosa of adults with active Crohn's disease (CD). Using microarray analysis on biopsy samples from inflamed (iCD) and non-inflamed (niCD) areas compared to healthy controls, researchers identified 43 upregulated and 35 downregulated miRNAs in iCD tissue. Notably, 3370 transcripts showed differential expression (2169 upregulated, 1201 downregulated) in iCD samples. Even niCD tissue demonstrated 20 significantly altered miRNAs, while nearly 100 miRNAs differed between iCD and niCD groups. Quantitative RT-PCR validated microarray findings. Luciferase assays confirmed hsa-miR-16-1 directly inhibits C10orf54 expression, showing negative correlation. Dysregulated miRNAs and mRNAs were associated with immune inflammation and intestinal microbiota alterations. Clinical relevance: These molecular signatures may eventually serve as biomarkers for disease activity and therapeutic targets, informing integrative treatment approaches that modulate inflammatory pathways in CD patients.